Imaging and biodistribution of radiolabeled SP90 peptide in BT-483 tumor bearing mice
Copyright © 2020 Elsevier Ltd. All rights reserved..
The objective of this study was to evaluate radiolabeled DOTA-SP90 as a radiotracer for breast cancer. The in vitro competition assay showed that radiolabeled DOTA-SP90 had significant binding affinity to BT-483 cancer cells. Biodistribution, nanoSPECT/CT and nanoPET/CT imaging results indicated that radiolabeled DOTA-SP90 can accumulate in tumors. In addition, radiolabeled DOTA-SP90 peptides can also detect metastatic tumors. Therefore, radiolabeled SP90 peptide may provide the potential capability as diagnostic agent for breast cancer patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:161 |
---|---|
Enthalten in: |
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine - 161(2020) vom: 14. Juli, Seite 109162 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lo, Wei-Lin [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 07.07.2021 Date Revised 07.07.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.apradiso.2020.109162 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311397794 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311397794 | ||
003 | DE-627 | ||
005 | 20231225142150.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.apradiso.2020.109162 |2 doi | |
028 | 5 | 2 | |a pubmed24n1037.xml |
035 | |a (DE-627)NLM311397794 | ||
035 | |a (NLM)32561130 | ||
035 | |a (PII)S0969-8043(20)30291-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lo, Wei-Lin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Imaging and biodistribution of radiolabeled SP90 peptide in BT-483 tumor bearing mice |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.07.2021 | ||
500 | |a Date Revised 07.07.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier Ltd. All rights reserved. | ||
520 | |a The objective of this study was to evaluate radiolabeled DOTA-SP90 as a radiotracer for breast cancer. The in vitro competition assay showed that radiolabeled DOTA-SP90 had significant binding affinity to BT-483 cancer cells. Biodistribution, nanoSPECT/CT and nanoPET/CT imaging results indicated that radiolabeled DOTA-SP90 can accumulate in tumors. In addition, radiolabeled DOTA-SP90 peptides can also detect metastatic tumors. Therefore, radiolabeled SP90 peptide may provide the potential capability as diagnostic agent for breast cancer patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a BT-483 | |
650 | 4 | |a DOTA-SP90 | |
650 | 4 | |a nanoPET/CT | |
650 | 4 | |a nanoSPECT/CT | |
650 | 7 | |a Gallium Radioisotopes |2 NLM | |
650 | 7 | |a Heterocyclic Compounds, 1-Ring |2 NLM | |
650 | 7 | |a Indium Radioisotopes |2 NLM | |
650 | 7 | |a Oligopeptides |2 NLM | |
650 | 7 | |a Radiopharmaceuticals |2 NLM | |
650 | 7 | |a SP90 peptide |2 NLM | |
650 | 7 | |a 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid |2 NLM | |
650 | 7 | |a 1HTE449DGZ |2 NLM | |
700 | 1 | |a Liang, Chen-Hsien |e verfasserin |4 aut | |
700 | 1 | |a Chen, Liang-Cheng |e verfasserin |4 aut | |
700 | 1 | |a Lee, Shih-Ying |e verfasserin |4 aut | |
700 | 1 | |a Lo, Sheng-Nan |e verfasserin |4 aut | |
700 | 1 | |a Chen, Ming-Wei |e verfasserin |4 aut | |
700 | 1 | |a Lu, Ruei-Min |e verfasserin |4 aut | |
700 | 1 | |a Liu, I-Ju |e verfasserin |4 aut | |
700 | 1 | |a Wu, Han-Chung |e verfasserin |4 aut | |
700 | 1 | |a Chang, Chih-Hsien |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine |d 1994 |g 161(2020) vom: 14. Juli, Seite 109162 |w (DE-627)NLM074730231 |x 1872-9800 |7 nnns |
773 | 1 | 8 | |g volume:161 |g year:2020 |g day:14 |g month:07 |g pages:109162 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.apradiso.2020.109162 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 161 |j 2020 |b 14 |c 07 |h 109162 |